Cost-Effectiveness of Low-Dose Antithymocyte Globulin Versus Other Immunotherapies for Treatment of New-Onset Type 1 Diabetes

Diabetes Technology&Therapeutics, Ahead of Print.

Source: Diabetes Technology and Therapeutics - November 18, 2021 Category: Endocrinology Authors: Hai V. Nguyen Desmond A. Schatz Shweta Mital Laura M. Jacobsen Michael J. Haller Source Type: research